Annual Press Conference 2011 - Boehringer Ingelheim
Annual Press Conference 2011 - Boehringer Ingelheim
Annual Press Conference 2011 - Boehringer Ingelheim
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Key Messages 2010<br />
125 years more health<br />
• 2010 – jubilee year<br />
• Value through innovation<br />
Net sales maintained<br />
• Loss of exclusivity (patents)<br />
• Decline in net sales of EUR 1.5bn<br />
almost compensated<br />
• Growth of ongoing business +5,5%<br />
<strong>Annual</strong> <strong>Press</strong> <strong>Conference</strong> <strong>2011</strong><br />
PRADAXA® launch<br />
• Convincing prescription figures<br />
• Integration into international<br />
treatment guidelines<br />
• Fundamental change of<br />
anticoagulation treatment<br />
Development portfolio<br />
• Considerable advances in late stage<br />
development portfolio<br />
• Expected launch of linagliptin in<br />
diabetes<br />
9
Change language